Background: Delirium is a frequent occurring complication in older people associated with mortality and dementia. A neuroinflammatory response has been suggested to cause delirium. Cerebrospinal fluid (CSF) is in close contact with the brain and might therefore reflect local changes. In this study we hypothesized that elderly hip fracture patients who develop a postoperative delirium have an altered CSF proteome. Methods: Patients of 75 years or older who were admitted for surgical repair of a hip fracture were included. CSF was collected during spinal anaesthesia. CSF proteins were separated by two-dimensional difference gel electrophoresis and identified with mass spectrometry. Results: We identified 8 different proteins: levels of contactin-1, complement factor C3, fibulin-1, and I-beta-1,3-N-acetylglucosaminyltransferase (B3GNT1) were lower in CSF of patients with postoperative delirium, while neural cell adhesion molecule-2 (NCAM2), fibrinogen, zincalpha-2-glycoprotein (ZAG) and haptoglobin were expressed higher in these patients. Discussion: Lower levels of C3 might be explained by complement activation, which induces splicing of C3, leading to a relative low level. Fibrinogen can bind to integrins on microglia, which induces several cell signalling responses such as activation of proinflammatory pathways. Higher CSF levels of fibrinogen might therefore contribute to neuroinflammation. The coagulation and complement systems are capable of activating each other, which might explain the pro-inflammatory state after trauma. We found higher levels of haptoglobin, an acute phase protein, whose secretion is increased by inflammation or injury. Haptoglobin-hemoglobin complexes can bind to a scavenger receptor exclusively expressed on cells of the monocyte-macrophage lineage, suggesting that haptoglobin is capable of inducing pro-inflammatory pathways by activating microglia. Large proteins such as fibrinogen and haptoglobin are banned from the healthy brain by the blood brain barrier (BBB), so elevation of these proteins in the CSF suggests BBB dysfunction in patients that are susceptible to postoperative delirium. Contactin, fibulin, NCAM2, B3GNT1 and ZAG were also found to be differentially expressed in patients with postoperative delirium, yet their role in delirium remains unknown. Conclusion: These results contribute to the theory that neuroinflammatory mechanisms contribute to the pathophysiology of delirium. The modification of the innate cell environment has recently been identified as a potential target for the treatment of autoimmune diseases. Of particular interest is Multiple Sclerosis (MS) which is an autoimmune disease affecting 1 in 1400 New Zealanders and may be a potential target for therapy with an innate cell modulator. MIS416 is an insoluble microparticle which targets myeloid cells by activating cytosolic receptors NOD2 and Toll-like receptor 9 (TLR) and has recently completed a phase 2a trial in the treatment of progressive MS. Using a mouse model of MS, EAE, we are identifying the mechanism by which activating these innate receptors can modify the immune environment which results in a reduction of disease pathology in both progressive and relapsing-remitting disease forms. In these mice many of the classic inflammatory aspects of EAE disease are down-regulated with weekly MIS416 treatment, including suppressed antigen-specific responses. Furthermore, there is a significant reduction in the number of infiltrating macrophages and T cells within the CNS of MIS416 treated EAE mice and these results also correlated with a significant reduction in both the number and size of lesions found in the spinal cord. Initial analysis on the integrity of the blood brain barrier (BBB) using Evans Blue dye shows that MIS416 treatment reduces the leakage and breakdown of the barrier seen in control EAE mice. These preliminary results suggest that by using the innate cell modulator MIS416 it is possible to reshape both the innate and T cell responses which suppress the CNS inflammation and paralysis that characterize EAE. 
